Roche's rheumatoid arthritis drug wins EU approval for extended use

[riky]

Roche's rheumatoid arthritis drug wins EU approval for extended use

<p><a href="http://news.yahoo.com/roches-rheumatoid-arthritis-drug-wins-eu-approval-extended-052205841--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/RVWjGZ4Zed7uAZMPiXhsFQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-09-08T052205Z_1_LYNXMPEA87042_RTROPTP_2_ROCHE-RESULTS.JPG" width="130" height="86" alt="The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel" align="left" title="The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel" border="0" /></a>Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid arthritis. Roche said the European Commission has backed RoActemra as a treatment for patients with severe, active and progressive rheumatoid arthritis who have previously not been treated with methotrexate. About 40 million people worldwide are affected by rheumatoid arthritis, a disease that causes joints to become chronically inflamed and swollen. RoActemra is already approved as a treatment for moderate-to-severe rheumatoid arthritis in patients who have failed to respond adequately or are intolerant to previous therapy.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login